# A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

> **NCT01874028** · PHASE1 · COMPLETED · sponsor: **Univar BV** · enrollment: 20 (actual)

## Conditions studied

- Wilson's Disease

## Interventions

- **DRUG:** trientine dihydrochloride

## Key facts

- **NCT ID:** NCT01874028
- **Lead sponsor:** Univar BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01874028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01874028, "A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01874028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*